Read the ACT program brochure to learn more about a special program designed for patients who have been prescribed ZOLINZA.

[PDF: 493 KB, 18 pages]

Download Your Guide to Treatment With ZOLINZA to learn more about what to expect from treatment with ZOLINZA.

[PDF: 1,154 KB, 9 pages]

Complete the ACT Enrollment Form with your doctor to enroll in this free program for patients taking ZOLINZA.

[PDF: 662 KB, 3 pages]

Read Support for People Being Treated With ZOLINZA for more information about life with CTCL and treatment with ZOLINZA.

[PDF: 2,089 KB, 31 pages]

The Weekly Tracker can help you remember to take your ZOLINZA and keep track of the liquids you drink each day. To make it even more useful, customize it by choosing side-effect management tips that you want to try.

[PDF: 321 KB, 1 page]

CTCL management tools

Download the Treatment Tracker to help you record all of your CTCL treatments, their doses, and your response to treatment.

[PDF: 19 KB, 1 page]

 

Download the Resource Tracker to help you record the organizations you have contacted and the services they offer.

[PDF: 41 KB, 1 page]

 

The CTCL Links newsletters provide helpful tips on managing CTCL. Download

Issue 1
[PDF: 285 KB, 4 pages]

Issue 2
[PDF: 490 KB, 4 pages]

Issue 3
[PDF: 375 KB, 4 pages]

Issue 4
[PDF: 267 KB, 4 pages]

to read the complete set of newsletters.

The Cutaneous Lymphoma Foundation brochure series. Merck has partnered with the Cutaneous Lymphoma Foundation to offer patients 3 informational brochures on CTCL and its treatment.

Living With CTCL
[PDF: 3,858 KB, 9 pages]

Taking an Active Role in Managing Your CTCL Care
[PDF: 2,482 KB, 7 pages]

Your CTCL Treatment Guide
[PDF: 1,103 KB, 5 pages]

To view PDF documents, you must
have Adobe Reader installed on your computer.

Important information about ZOLINZA

ZOLINZA is a medicine used to treat a type of cancer called cutaneous T-cell lymphoma, also called CTCL. ZOLINZA is used in patients when the CTCL gets worse, does not go away, or comes back after treatment with other medicines.

• Before taking ZOLINZA, tell your doctor if you have had a blood clot in your lung or in a vein anywhere in your body, if you have heart problems, if you have high blood sugar or diabetes, or if you have nausea, vomiting, or diarrhea.
• Tell your doctor about all the prescription medicines you are taking, especially valproic acid (to treat seizures) or a blood thinner such as Coumadin (warfarin), as well as nonprescription medicines, vitamins, and herbal supplements.
• If you are pregnant or plan to become pregnant, you should tell your doctor because ZOLINZA may harm your unborn baby. You should discuss with your doctor whether to breast-feed your baby while taking ZOLINZA.
• While taking ZOLINZA, tell your doctor if you have sudden sharp chest pain, shortness of breath, cough with blood, sweating, rapid pulse, anxiety, or fainting because these may be signs of a serious side effect.
• Please read the Patient Information for ZOLINZA and discuss it with your doctor. The physician Prescribing Information also is included on this site.
• You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.